CytRx Corp. (CYTR) to Present Positive, Stroke-Related Discovery at Sixth International Workshop in Thailand
CytRx Corp. (Nasdaq: CYTR) today announced Shi Chung Ng, Ph.D., the biopharmaceutical company’s senior vice president of research and development, will present results of its recent studies at the Sixth International Workshop on the Molecular Biology of Stress Responses at the Chulabhorn Research Institute in Bangkok, Thailand. CytRx is engaged in the development and commercialization of human therapeutics through animal testing. It recently conducted studies surrounding animal stroke and the company’s lead molecular chaperone amplification drug candidate arimoclomol, which Dr. Ng will present at the upcoming workshop. In the press release, Dr. Ng said most previous-generation stroke drug candidates were…